150 related articles for article (PubMed ID: 14969753)
1. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery.
Gabor F; Bogner E; Weissenboeck A; Wirth M
Adv Drug Deliv Rev; 2004 Mar; 56(4):459-80. PubMed ID: 14969753
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the glycosylation pattern of monocytic THP-1 cells upon differentiation and its impact on lectin-mediated drug delivery.
Plattner VE; Ratzinger G; Engleder ET; Gallauner S; Gabor F; Wirth M
Eur J Pharm Biopharm; 2009 Nov; 73(3):324-30. PubMed ID: 19602437
[TBL] [Abstract][Full Text] [Related]
3. Lectin bioconjugates trigger urothelial cytoinvasion--a glycotargeted approach for improved intravesical drug delivery.
Neutsch L; Eggenreich B; Herwig E; Marchetti-Deschmann M; Allmaier G; Gabor F; Wirth M
Eur J Pharm Biopharm; 2012 Oct; 82(2):367-75. PubMed ID: 22889683
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two blood-brain barrier mimicking cell lines: distribution of lectin-binding sites and perspectives for drug delivery.
Plattner VE; Germann B; Neuhaus W; Noe CR; Gabor F; Wirth M
Int J Pharm; 2010 Mar; 387(1-2):34-41. PubMed ID: 19963051
[TBL] [Abstract][Full Text] [Related]
5. Lectin-mediated drug delivery: discrimination between cytoadhesion and cytoinvasion and evidence for lysosomal accumulation of wheat germ agglutinin in the Caco-2 model.
Wirth M; Kneuer C; Lehr CM; Gabor F
J Drug Target; 2002 Sep; 10(6):439-48. PubMed ID: 12575733
[TBL] [Abstract][Full Text] [Related]
6. Targeted drug delivery: binding and uptake of plant lectins using human 5637 bladder cancer cells.
Plattner VE; Wagner M; Ratzinger G; Gabor F; Wirth M
Eur J Pharm Biopharm; 2008 Oct; 70(2):572-6. PubMed ID: 18602465
[TBL] [Abstract][Full Text] [Related]
7. Lectin-mediated drug delivery: influence of mucin on cytoadhesion of plant lectins in vitro.
Wirth M; Gerhardt K; Wurm C; Gabor F
J Control Release; 2002 Feb; 79(1-3):183-91. PubMed ID: 11853930
[TBL] [Abstract][Full Text] [Related]
8. Lectin mediated biorecognition as a novel strategy for targeted delivery to bladder cancer.
Neutsch L; Plattner VE; Polster-Wildhofen S; Zidar A; Chott A; Borchard G; Zechner O; Gabor F; Wirth M
J Urol; 2011 Oct; 186(4):1481-8. PubMed ID: 21855917
[TBL] [Abstract][Full Text] [Related]
9. Glycan-mediated uptake in urothelial primary cells: Perspectives for improved intravesical drug delivery in urinary tract infections.
Pichl CM; Feilhauer S; Schwaigerlehner RM; Gabor F; Wirth M; Neutsch L
Int J Pharm; 2015 Nov; 495(2):710-8. PubMed ID: 26383837
[TBL] [Abstract][Full Text] [Related]
10. Development of a sensitive and reliable ELISA for quantification of wheat germ agglutinin.
Güll I; Wirth M; Gabor F
J Immunol Methods; 2007 Jan; 318(1-2):20-9. PubMed ID: 17141264
[TBL] [Abstract][Full Text] [Related]
11. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
[TBL] [Abstract][Full Text] [Related]
12. Effect of lectins on the transport of food factors in caco-2 cell monolayers.
Ohno Y; Naganuma T; Ogawa T; Muramoto K
J Agric Food Chem; 2006 Jan; 54(2):548-53. PubMed ID: 16417319
[TBL] [Abstract][Full Text] [Related]
13. Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution.
Yin Y; Chen D; Qiao M; Wei X; Hu H
J Control Release; 2007 Oct; 123(1):27-38. PubMed ID: 17728000
[TBL] [Abstract][Full Text] [Related]
14. Micromachined devices: the impact of controlled geometry from cell-targeting to bioavailability.
Tao SL; Desai TA
J Control Release; 2005 Dec; 109(1-3):127-38. PubMed ID: 16274828
[TBL] [Abstract][Full Text] [Related]
15. Lectin-mediated drug targeting: history and applications.
Bies C; Lehr CM; Woodley JF
Adv Drug Deliv Rev; 2004 Mar; 56(4):425-35. PubMed ID: 14969751
[TBL] [Abstract][Full Text] [Related]
16. Lectin binding and endocytosis at the apical surface of human airway epithelia.
Yi SM; Harson RE; Zabner J; Welsh MJ
Gene Ther; 2001 Dec; 8(24):1826-32. PubMed ID: 11821935
[TBL] [Abstract][Full Text] [Related]
17. Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles.
Gao X; Wang T; Wu B; Chen J; Chen J; Yue Y; Dai N; Chen H; Jiang X
Biochem Biophys Res Commun; 2008 Dec; 377(1):35-40. PubMed ID: 18823949
[TBL] [Abstract][Full Text] [Related]
18. M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
Jepson MA; Clark MA; Hirst BH
Adv Drug Deliv Rev; 2004 Mar; 56(4):511-25. PubMed ID: 14969756
[TBL] [Abstract][Full Text] [Related]
19. Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model.
Gabor F; Schwarzbauer A; Wirth M
Int J Pharm; 2002 Apr; 237(1-2):227-39. PubMed ID: 11955820
[TBL] [Abstract][Full Text] [Related]
20. Lectin-mediated drug delivery: the second generation of bioadhesives.
Lehr CM
J Control Release; 2000 Mar; 65(1-2):19-29. PubMed ID: 10699266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
